Essential Partners’s Kestra Medical Technologies KMTS Stock Holding History

Essential Partners’s Portfolio KMTS Stock Details KMTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.91K	Sell	103 -1	-1%	-$25	﹤0.01%	1771
2026 Q2	$2.65K	Sell	104 -1	-1%	-$21	﹤0.01%	1856
2026 Q1	$2.09K	Buy	105 +1	+1%	+$24	﹤0.01%	1991
2025 Q4	$2.76K	Hold	104	–	–	﹤0.01%	1689
2025 Q3	$2.47K	Buy	+104	New	+$1.86K	﹤0.01%	1721

Other funds holding KMTS

Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners's KMTS Position: Q3 2026 in Review

Essential Partners reduced its Kestra Medical Technologies (KMTS) stake by 0.96% in Q3 2026, selling an estimated $25 and leaving 103 shares worth $2.91K. The position accounts for ﹤0.01% of the portfolio, ranked #1771.

Essential Partners first reported a position in KMTS in Q3 2025 and has held it in 5 quarters since. 6 funds tracked by Wall St. Rank hold KMTS as of Q3 2026.

Essential Partners held 103 shares of Kestra Medical Technologies worth $2.91K as of Q3 2026.
Essential Partners sold 1 Kestra Medical Technologies share in Q3 2026, an estimated $25.
Kestra Medical Technologies made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1771 holding.
Essential Partners first reported a position in Kestra Medical Technologies in Q3 2025 and has held it in 5 quarters since.
6 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.